# About this plain guide to joint soreness and PRP

*About This Joint Guide | PRP Mesa*

> PRP Mesa gives direct help with aching joints, PRP choices, urgent symptoms, local routes, and the ownership behind this guide.

This page tells you who runs the site and where its limits begin. We'll also state the owners' financial interest in plain words. You deserve to know both.

## A website cannot tell what is causing your soreness

A website can't move your joint, check swelling, or read an X-ray with you. It can't decide whether a blood thinner changes the risk of a procedure. Your doctor can make those checks during an exam. Use these pages as a starting point, not a diagnosis.

You can note which movement hurts and how the ache changes your day. Old X-rays may also help the clinician understand what has already been found. Urgent symptoms still need prompt medical care. Please don't wait on a website when you feel very ill.

## The clinic owners may gain money from your care

This publication is operated by the owners of the QC Kinetix Phoenix-area clinics, including the Chandler and Scottsdale offices named in the local access section. In plain terms, the business may make money if you become a patient. That fact may matter as you weigh the site's recommendation, and we want it stated clearly.

The ownership doesn't tell you what is causing the ache. It also doesn't show whether one procedure suits your health. Those answers require an exam and an honest talk about other choices, and you may take time before deciding.

## If soreness continues, a consultation can begin with an exam

You may arrange a QC Kinetix consultation when soreness won't settle. It provides regenerative treatment options, a name for non-surgical care the clinic makes using material drawn from your blood. PRP, or platelet-rich plasma, is one choice made by spinning that blood and saving fluid with many platelets for a syringe. Platelets help clot a cut and send early repair signals.

At the visit, medical providers are the clinicians who examine you before discussing care. They can review your health, older X-rays, and the treatments you've tried. The exam may support another choice instead, and you won't be expected to decide before hearing that explanation.

## Sources

1. The devices used to spin PRP at the point of care are cleared by FDA as clinical centrifuges, product code JQC, a Class I device under 21 CFR 862.2050 - for example the Biomet GPS Platelet Separation Kit (K030555, cleared 2003) and the Harvest SmartPrep2 / SmartPrep Platelet Concentration System (K103340, cleared 2010). That clearance covers the equipment that separates blood. It is not an FDA approval of platelet-rich plasma as a treatment for osteoarthritis, tendinopathy or any other orthopedic condition, and copy must never blur the two.
   U.S. Food and Drug Administration (Center for Devices and Radiological Health) — [510(k) Premarket Notification database and Product Classification: JQC, Centrifuges (Micro, Ultra, Refrigerated) For Clinical Use, 21 CFR 862.2050](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/classification.cfm?ID=JQC). *FDA accessdata (CDRH device databases)*, 2003.
2. The American Academy of Physical Medicine and Rehabilitation convened a technical expert panel that ran a structured literature review (2023, updated through June 2025) and a modified Delphi process, and issued five evidence-based clinical recommendations plus 11 consensus-based best practices for PRP in knee osteoarthritis. The statement is explicit that orthobiologic therapies 'remain an evolving area of practice' and that robust, dose-dependent randomized controlled trials are still needed to establish PRP's clinical effects.
   Borg-Stein J, Jayaram P, Colorado BS, et al. — [AAPM&R guidance statement on platelet rich plasma for knee osteoarthritis](https://pubmed.ncbi.nlm.nih.gov/41989317/). *PM&R*, 2026. DOI: 10.1002/pmrj.70144.
3. In the RESTORE trial - the largest placebo-controlled PRP trial in knee osteoarthritis - 288 adults aged 50+ with symptomatic Kellgren-Lawrence grade 2-3 medial knee OA received three weekly intra-articular injections of leukocyte-poor PRP from a commercial system or saline placebo. At 12 months the mean change in knee pain was -2.1 points with PRP versus -1.8 with saline (difference -0.4; 95% CI -0.9 to 0.2; P=.17) against a minimum clinically important difference of 1.8, and the change in medial tibial cartilage volume was -1.4% versus -1.2% (difference -0.2%; 95% CI -1.9% to 1.5%; P=.81). Twenty-nine of 31 prespecified secondary outcomes showed no significant between-group difference. The authors concluded the findings do not support use of PRP for knee OA.
   Bennell KL, Paterson KL, Metcalf BR, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415.
4. A meta-analysis of eight studies (648 patients, mean age 59) judged at low risk of bias found PRP significantly better than intra-articular corticosteroid for knee OA symptoms at 3, 6 and 9 months (P<0.01), with the largest effects at 6 months (SMD -0.78; 95% CI -1.34 to -0.23) and 9 months (SMD -1.63; 95% CI -2.14 to -1.12). This is the strongest available case for PRP as a longer-acting alternative to a steroid shot.
   McLarnon M, Heron N — [Intra-articular platelet-rich plasma injections versus intra-articular corticosteroid injections for symptomatic management of knee osteoarthritis: systematic review and meta-analysis](https://pubmed.ncbi.nlm.nih.gov/34134679/). *BMC Musculoskeletal Disorders*, 2021. DOI: 10.1186/s12891-021-04308-3.
5. A systematic review of 105 clinical PRP studies in orthopaedics published 2006-2016 found that only 11 (10%) described the preparation protocol clearly enough for another investigator to repeat it, and only 17 (16%) reported any quantitative metric of the final PRP composition. The authors concluded that the current reporting of PRP preparation and composition does not allow the PRP products actually delivered to patients to be compared between studies.
   Chahla J, Cinque ME, Piuzzi NS, et al. — [A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting: A Systematic Review of the Clinical Orthopaedic Literature](https://pubmed.ncbi.nlm.nih.gov/29040132/). *Journal of Bone and Joint Surgery (American)*, 2017. DOI: 10.2106/JBJS.16.01374.

## A clinic can examine soreness that keeps returning

When the ache hasn't settled, QC Kinetix has regenerative treatment options. In plain words, this is non-surgical care made at the clinic with material drawn from your blood. One choice is PRP, or platelet-rich plasma, prepared by spinning the blood and saving fluid with many platelets. Those cells help a cut clot and send repair signals.

The clinicians serving as medical providers examine you and consider your health and earlier care first. Most Mesa readers use Chandler. North and northeast Mesa may find Scottsdale easier, and you can call (602) 837-PAIN when you're ready to talk.

Book a free consultation: <https://prp.qckaz.com/?src=prpmesa.com>

---

A calm welcome for the joint that hurts.

PRP Mesa covers lasting soreness, simple relief at home, warning signs, and what happens during a clinic visit.

Mesa answers for readers who are weighing care for an aching joint.

This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including the Chandler and Scottsdale offices named here, and the business may benefit when a reader books a consultation.

Copyright 2026 Mesa PRP Label Guide. General education only; a web page cannot diagnose a joint or replace care from a qualified medical professional.
